☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Initiation
Merck and Ridgeback Report the Initiation of EMA Rolling Review of Molnupiravir for the Treatment of COVID-19
October 25, 2021
Merck and Ridgeback Report the Initiation of EMA Rolling Review of Molnupiravir for the Treatment of COVID-19
October 25, 2021
PharmaShots Interview: Rain Therapeutic's Avanish Vellanki Shares Insight on the Initiation of P-III MANTRA Trial of Milademetan f...
August 23, 2021
PharmaShots Interview: Rain Therapeutic's Avanish Vellanki Shares Insight on the Initiation of P-III MANTRA Trial of Milademetan f...
August 23, 2021
Bio-Thera Reports the Initiation of P-III Clinical Trial for BAT2506 (biosimilar- golimumab)
June 9, 2021
Bio-Thera Reports the Initiation of P-III Clinical Trial for BAT2506 (biosimilar- golimumab)
June 9, 2021
Load more...
Back to Home